Eucalyptus Bio

Startup

Eucalyptus Bio is a pre-clinical stage company which has developed a unique corrective long-range CRISPR based gene editing technology (CRISP-HR) that enables the treatment of diverse pathogenic casual mutations in genetic diseases with a single therapeutic molecule. We anticipate our platform will unlock hundreds of indications currently not addressable with other approaches and have already identified a handful of extremely high quality and exciting indications which we believe will demonstrate the tremendous power of our platform.



website


Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

 

To speak


Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150